Refractory cancer pain and drug-related toxicity controlled by an implantable drug delivery system

2005 ◽  
Vol 2 (7) ◽  
pp. 329-330
Keyword(s):  
Drug Delivery ◽  
Cancer Pain ◽  
Drug Delivery System ◽  
Delivery System

scholarly journals Efficacy of intrathecal drug delivery system for refractory cancer pain patients: A single tertiary medical center experience

2012 ◽  
Vol 111 (5) ◽  
pp. 253-257 ◽  
Author(s):  
Chih-Peng Lin ◽  
Wen-Ying Lin ◽  
Feng-Sheng Lin ◽  
Yow-Shan Lee ◽  
Chuen-Shin Jeng ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Cancer Pain ◽  
Drug Delivery System ◽  
Delivery System ◽  
Medical Center ◽  
Intrathecal Drug Delivery ◽  
Pain Patients

Intrathecal Drug Delivery System (IDDS) for Cancer Pain Management

2011 ◽  
Vol 29 (5) ◽  
pp. 388-398 ◽  
Author(s):  
Surjya Prasad Upadhyay ◽  
Piyush N. Mallick
Keyword(s):  
Drug Delivery ◽  
Pain Management ◽  
Cancer Pain ◽  
Drug Delivery System ◽  
Delivery System ◽  
Cancer Pain Management ◽  
Patients With Cancer ◽  
Intrathecal Drug Delivery ◽  
Number Of Patients ◽  
Interventional Pain Management

Cancer pain remains undertreated and a significant number of patients with cancer pain die from severe untreated pain. With increasing survival rate in cancer, the prevalence of cancer pain is also increasing in number. Though majority of patients with cancer pain can be effectively treated with conventional medical management, still a significant portion of patients required some form of interventional pain management techniques. Among the interventional techniques, intrathecal drug delivery is increasingly used in cancer pain management. Our objective of this article is to review literatures and clinical studies on intrathecal drug delivery system (IDDS) in cancer pain management and to provide updates on its use, precautions, contraindications, side effects and its management, socioeconomic consideration, and management of IDDS in difficult or uncommon situations.

Sign in / Sign up

Export Citation Format

Share Document